G

Grand Pharmaceutical Group Ltd
HKEX:512

Watchlist Manager
Grand Pharmaceutical Group Ltd
HKEX:512
Watchlist
Price: 4.74 HKD -0.42% Market Closed
Market Cap: 16.6B HKD
Have any thoughts about
Grand Pharmaceutical Group Ltd?
Write Note

Grand Pharmaceutical Group Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Grand Pharmaceutical Group Ltd
Operating Income Peer Comparison

Comparables:
U
3933
1177
C
570
C
3320
H
13

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
G
Grand Pharmaceutical Group Ltd
HKEX:512
Operating Income
HK$2.7B
CAGR 3-Years
9%
CAGR 5-Years
17%
CAGR 10-Years
26%
U
United Laboratories International Holdings Ltd
HKEX:3933
Operating Income
ÂĄ3.7B
CAGR 3-Years
39%
CAGR 5-Years
33%
CAGR 10-Years
13%
Sino Biopharmaceutical Ltd
HKEX:1177
Operating Income
ÂĄ6.4B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
15%
C
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Operating Income
ÂĄ993.8m
CAGR 3-Years
-28%
CAGR 5-Years
-15%
CAGR 10-Years
9%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Operating Income
HK$19.6B
CAGR 3-Years
23%
CAGR 5-Years
10%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Operating Income
-$120.8m
CAGR 3-Years
23%
CAGR 5-Years
-2%
CAGR 10-Years
-77%

See Also

What is Grand Pharmaceutical Group Ltd's Operating Income?
Operating Income
2.7B HKD

Based on the financial report for Jun 30, 2024, Grand Pharmaceutical Group Ltd's Operating Income amounts to 2.7B HKD.

What is Grand Pharmaceutical Group Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
26%

Over the last year, the Operating Income growth was 3%. The average annual Operating Income growth rates for Grand Pharmaceutical Group Ltd have been 9% over the past three years , 17% over the past five years , and 26% over the past ten years .

Back to Top